Business Development Strategist who applies healthcare industry market knowledge and insights to identify high impact strategies for growth. Breadth of experience in early and growth-stage molecular diagnostics working with over 30 companies spanning industry leaders to inventive start-ups. A respected analyst capable of applying highly effective models to target emerging markets, assess risk, build business cases, identify challenges and quantify value creation. Collaborative and valued contributor who leads with integrity, communicates effectively with cross-functional teams building a shared vision to capitalize on new opportunities and deliver market growth. ➤ IDENTIFIES BUSINESS DEVELOPMENT OPPORTUNITIES: applies a broad view of the competitive environment delivering valued insights on emerging strategies in molecular diagnostics. Supported multiple diligence efforts and acquisitions with transaction values up to $100M. ➤ DEVELOPS PRODUCT/PORTFOLIO STRATEGY: leads domestic and global strategy development for multiple clinical oncology products with $1B+ TAMs. Aligns the right technology, partnerships with an integrated and cohesive vision for the diagnostics portfolio mitigating risk and delivering market impact. ➤ BUILDS CONSENSUS: Supported resource allocation across $100M+ product pipelines, working cross-functionally with R&D, Operations, Technology, Marketing, Sales, and Product Data teams. Facilitates dialog with heatmapping exercises fostering a team culture, shared purpose and innovation mindset. ➤TURNS INSIGHTS INTO ACTION: applying market models, analytics, quantitative and qualitative voice-of-customer research, demand modeling, and data analysis to make sense of the market. Builds a nimble organization capable of factoring insights into broader strategy ensuring success in dynamic environments.